AbbVie’s Tavapadon Demonstrates Efficacy In Parkinson’s Monotherapy Study

 
• By Joseph Haas
  
AbbVie exterior
AbbVie is looking to treat early-stage Parkinson's with tavapadon • Source: Alamy

More from Clinical Trials

More from R&D